[
    [
        {
            "time": "2021-12-09",
            "original_text": "固生堂、凯莱英及北海康成明天上市 腾盛博药治疗新冠肺炎症中和抗体联合疗法获批上市",
            "features": {
                "keywords": [
                    "固生堂",
                    "凯莱英",
                    "北海康成",
                    "腾盛博药",
                    "新冠肺炎症",
                    "中和抗体",
                    "联合疗法",
                    "获批上市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "固生堂、凯莱英及北海康成明天上市 腾盛博药治疗新冠肺炎症中和抗体联合疗法获批上市",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "BioNTech公布最新实验数据，三针mRNA新冠疫苗BN162b2可有效中和奥密克戎变异病毒",
            "features": {
                "keywords": [
                    "BioNTech",
                    "mRNA",
                    "新冠疫苗",
                    "奥密克戎",
                    "变异病毒",
                    "实验数据"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "BioNTech公布最新实验数据，三针mRNA新冠疫苗BN162b2可有效中和奥密克戎变异病毒",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "复星医药：拟对天津星耀进行减资 减资破产",
            "features": {
                "keywords": [
                    "复星医药",
                    "天津星耀",
                    "减资",
                    "破产"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药：拟对天津星耀进行减资 减资破产",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "复星医药拟为复星健康不超过1.5亿元贷款提供担保 大额借贷担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "复星健康",
                    "贷款",
                    "担保",
                    "大额借贷"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药拟为复星健康不超过1.5亿元贷款提供担保 大额借贷担保",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "复星医药：集团实际对外担保金额约合人民币约197.02亿元 大额借贷担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "对外担保",
                    "金额",
                    "大额借贷"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药：集团实际对外担保金额约合人民币约197.02亿元 大额借贷担保",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "复星医药产业拟以400万元受让星创健康科技87%股权",
            "features": {
                "keywords": [
                    "复星医药",
                    "星创健康科技",
                    "受让",
                    "股权"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药产业拟以400万元受让星创健康科技87%股权",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "复星医药：子公司拟以2870万美元受让FMH45%股权",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "FMH",
                    "受让",
                    "股权"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药：子公司拟以2870万美元受让FMH45%股权",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "港股异动 | 复星医药(02196)午后涨超5% 宣布将与BioNTech研发针对奥密克戎毒株的疫苗",
            "features": {
                "keywords": [
                    "复星医药",
                    "BioNTech",
                    "奥密克戎",
                    "疫苗",
                    "异动"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动 | 复星医药(02196)午后涨超5% 宣布将与BioNTech研发针对奥密克戎毒株的疫苗",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "【异动股】复星医药(02196.HK)涨4.38%",
            "features": {
                "keywords": [
                    "复星医药",
                    "异动股",
                    "涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】复星医药(02196.HK)涨4.38%",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "“毒”性到底强不强？实验数据不断出炉，奥密克戎“精准画像”开始浮现",
            "features": {
                "keywords": [
                    "奥密克戎",
                    "毒性",
                    "实验数据",
                    "精准画像"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "“毒”性到底强不强？实验数据不断出炉，奥密克戎“精准画像”开始浮现",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]